Regulatory Translation of Generic Medication Product Information in the European Union
Diana Sánchez, Nova Language Services
This presentation will discuss European legislation requirements for generic medication approval and share general considerations on how to proceed when translating product information (SmPC), Patient Information Leaflets (PIL) and labeling. In order to obtain final approval from the European Medicines Agency, translators are required to closely follow previously existing templates, often adapting content with no source text in hand. We will illustrate translation adaptation examples, focusing on the quality control methods applied to ensure compliance, and cover regulatory requirement differences between the United States and Europe.